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ABSTRACT
Objective: The aim of this study is to evaluate using PFS-TV the mid-term results of our first operative experience with 
implanting a single incision sling — Ajust™.
Material and methods: One and the same surgeon has operated all the patients with symptoms of stress urinary incon-
tinence. Ajust was the only performed procedure. Postoperative evaluation consisted of: a standardized interview and 
examination, a cough test and a PFS-TV for evaluation of urinary continence and tape location. PFS-TV was performed 
under standardized conditions at rest and during maximum Valsalva maneuver. 
Results: This is a retrospective analysis of data from a total of 31 patients who attended a control visit between the 36th and 
the 50th month following the operation. Sixteen patients (51.6%) were cured. There were statistically significant differences 
in urethral mobility (p < 0.0007) and tape-urethra distance (p < 0.002) between cured and not-cured group. The difference in 
urethral length was not statistically significant. 77.8% of women with a hypermobile urethra was cured in contrast to 15.4% 
with a normobile urethra. Neither of the groups had a hypomobile urethra patient. There were no significant complications 
intra- or post-operatively. De novo urgency was observed in 1 patient only.
Conclusions: Implantation of Ajust tape seems to be a safe mode of operative treatment for SUI in women. Our mid-term 
results suggest that long term effects might be worse compared to retropubic or transobturator tapes, especially at first 
operative experience with Ajust. Urethral mobility seems to be an important risk factor for treatment failure after Ajust 
implantation. It seems that patients that may benefit from Ajust most are women with urethral hypomobility but this needs 
to be verified with a prospective study.
Key words: stress urinary incontinence, mini-sling, suburethral sling, pelvic floor ultrasound, PFS-TV, transvaginal probe
Ginekologia Polska 2017; 88, 8: 407–413
Corresponding author:
Tomasz Kluz
Department of Obstetrics and Gynecology, Fryderyk Chopin University Hospital No. 1
Faculty of Medicine, Rzeszow University
Szopena 2, 35–055 Rzeszów, Poland
e-mail: jtkluz@interia.pl
INTRODUCTION
Stress urinary incontinence (SUI) is the most common 
type of urinary incontinence (UI) in women [1–4]. Although 
it may be treated conservatively, many women need to 
be operated [5]. Over 20 years ago it was suggested that 
mid-urethra played a pivotal role in achieving urinary conti-
nence. Suburethral retropubic tape TVT was then introduced 
and showed a high treatment efficacy with long lasting 
effects [5–11]. Introital pelvic floor sonography performed 
with a transvaginal probe (PFS-TV) showed to be useful in 
evaluating the implanted suburethral tapes. Studies based 
on PFS-TV have confirmed that results are best when the TVT 
tape is placed at the level of mid-urethra [12–14]. However, 
TVT implantation is associated with potential complications 
such as bladder perforation or vessel injuries so TVT gave 
ground to a transobturator tape (TOT) as alternative. The 
route of implantation of TOT allows to bypass the retropubic 
space, and hence to avoid many complications associated 
with TVT tape implantation [15]. PFS-TV has proved useful 
in visualizing the differences in biomechanical properties 
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between TVT and TOT, which led to modifications of TOT 
implantation technique so to optimize the results [12, 13]. 
Yet, after TOT implantation some other complications were 
observed such as thigh and groin pain, which usually has 
a very negative impact on patient’s quality of life [16, 17]. To 
avoid such complications a single-incision-mini-sling (SIMS) 
TVT-Secur™ was introduced but poor midterm results have 
led to cessation of this product by the company [18]. 
There are differences between various SIMS. Ajust™ (C.R. 
Bard Inc., New Providence, NJ, USA) for instance should be 
anchored directly on the obturator muscle or membrane 
and it is possible to regulate the tension of this sling [19]. 
Ultrasound studies suggested that one year after implanta-
tion of SIMS, Ajust™ has the same quality of tape fixation 
as TVTO [20]. 
OBJECTIVE
The aim of this study is to evaluate using PFS-TV the 
mid-term results of SIMS Ajust™ implantation.
MATERIAL AND METHODS
All patients who were qualified for Ajust tape implanta-
tion had symptoms of SUI with significant impact on quality 
of life as the predominant compliant. One and the same 
experienced surgeon (T.K.) operated all of the patients in-
cluded in this study. 
Patients were examined pre-operatively under standard-
ized conditions. Pelvic organ prolapse (POP) was classified in 
accordance with POP-Q system [21–25]. SUI was confirmed 
by a cough test [26].
Ajust implantations were performed according to 
a standardized technique [19]. Operations were performed 
under spinal epidural anesthesia. Foley catheter was re-
moved a day after the operation and post-void residual 
was checked.
Postoperative evaluation consisted of: standardized in-
terview and examination, cough test and PFS-TV to evaluate 
urinary continence, tape location and symmetry. If cough 
test performed in patients in lithotomy position was nega-
tive, it was repeated in standing.
Specialists experienced in pelvic floor ultrasound per-
formed an ultrasound examination on GE Voluson 730 Ex-
pert using a transabdominal transducer of 3.5 MHz fre-
quency and a transvaginal transducer of 6.5 MHz frequency. 
The volume of urine in the bladder was evaluated during 
the transabdominal ultrasound by performing three-plane 
measurements of the bladder followed by calculations per-
formed by the ultrasound system. We evaluated urinary 
continence, tape location and its symmetry in a condition 
where all patients had 250–350 [mL] of urine in the blad-
der. PFS-TV was performed introitally using a transvaginal 
probe of high-frequency (6.5 MHz, 160° beam angle ultra-
sound) at rest and during maximum Valsalva maneuver, all 
in accordance to standardized conditions developed by 
Kociszewski [12, 13]. 
At the post-operative visit the length of urethra, ure-
thral mobility and urethral funneling were evaluated during 
PFS-TV in a sagittal plane, as described previously [12, 13, 25, 
26]. Urethral mobility was evaluated with a vector calculated 
from measurements obtained during PFS-TV according to 
the method specified by Viereck [13, 25]. A hypomobile 
urethra was defined as a vector value ≤ 5 [mm], normobile 
urethra as a vector value between 5 and 15 [mm], hypermo-
bile urethra as a vector value ≥ 15 [mm] [13, 14]. We used the 
PFS-TV examination during Valsalva maneuver to observe 
urethral funneling with urine flow (long urethral funneling), 
which we regard as a confirmation of SUI reported by pa-
tients with a positive cough test (SUI+ group) (Figure 1) [26]. 
In the absence of clinical SUI symptoms or when the patient 
Figure 1. PFS-TV — evaluation of urethral funneling (sagittal plane). 
A. Short urethral funneling (without urine flow), tape cured SUI; 
B. Long urethral funneling (with urine flow), tape did not cure 
SUI. Legend: Bl — bladder, U — urethra, arrow T — tape, arrow 
— funneling (in agreement with the technique first introduced  
by J. Kociszewski [26])
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observed SUI only periodically with a negative sitting and 
standing cough test we diagnosed no SUI. In these patients 
no signs of SUI during PFS-TV was found. Namely, there 
was either no urethral funneling or the urethral funneling 
was on short distance but there was no urine flow (short 
urethral funneling). Such patients make up the SUI0 group 
(Figure 1) [26].  J. Kociszewski was first who introduced the 
technique of ultrasound evaluation of urethral funneling as 
well as concept of short and long urethral funneling, which 
we used in the study [26].
The location of Ajust sling was defined during PFS-TV in 
a sagittal plane similarly to the measurements proposed by 
Kociszewski et al. (Figure 2) [12, 13]. The shortest distance 
between the tape and the hypoechoic urethra was meas-
ured in [mm]. It was called a tape-urethra distance. Next, we 
calculated the tape position relative to the urethral length 
in% according to the following formula (1):
Relative tape position = distance of the middle part 
o the tape from the bladder neck × 100%/sonographic 
urethral length.
The symmetry of the tape was analyzed in axial plane. 
Statistical analysis was carried out using STATISTICA 7.0 of 
StatSoft. Median, arithmetic mean and standard deviations 
were calculated. Student’s t-test was applied for testing the 
significance of differences for dependent variables.
RESULTS
This study is a retrospective analysis of data from 31 pa-
tients (a total of operated patients = 39) that attended a con-
trol visit between the 36th and the 50th month following 
the operation. The mean age of patients was 59.5 years 
(range = 44–80), mean BMI was 28.8 kg/m2 (range = 21.5–
–36.5), mean parity was 2 (range = 1–5). The majority of 
women have had a spontaneous delivery. Two women had 
a caesarean section apart of 2 and 4 spontaneous deliveries, 
respectively. One patient had vacuum apart from a spon-
taneous delivery. There were no statistically significant dif-
ferences in age, BMI or parity between groups SUI0 and 
SUI+. Ten women were on anti-hypertensive drugs and one 
patient was on insulin. Three women suffered from asthma. 
Five women had hysterectomy in the past: four abdominal 
and one — vaginal. One patient had previously a vaginal re-
pair surgery and one had Burch colposuspension procedure.
All of the women had SUI with a considerable impact 
on their quality of life and none had clinically significant 
vaginal prolapse. The Ajust tape implantation was the only 
treatment implemented. At the control visit the treatment 
was successful (SUI0) in 16 patients (51.6%) and unsuccessful 
(SUI+) in 15 (48.4%) patients. Before the operation a total of 
11 women had symptoms of overactive bladder (OAB) and 
none of them were treated pharmacologically. After the op-
eration, in 8 cases out of 11 the OAB symptoms have persisted. 
One patient has observed urgency de novo after surgery.
Statistically significant differences between SUI0 group 
and SUI+ group postoperatively concern the urethral mobil-
ity (p < 0.0007) and the tape-urethra distance (p < 0.002). 
The difference in urethral length or relative tape position 
between the groups was not statistically significant. 
The median value of the urethral mobility vector 
was 22.9 [mm] (range = 8.0–34.3) for SUI0 group and 
11.9 [mm] (range = 6.5–21.4) for SUI+ group, while the me-
dian tape-urethra distance was 3.5 [mm] (range = 1.9–6.1) 
and 6.1 [mm] (range = 2.5–8.5), respectively. There was 
no case of a hypomobile urethra (vector value ≤ 5 mm) in 
neither of the groups (Figure 3).
The median of urethral length was 30.1 [mm] 
(range = 24.3–38.1) for SUI0 group and 28.2 [mm] (21.6–36.8) 
Figure 2. PFS-TV — evaluation of tape location (sagittal plane).  
A. Relative tape position: 13,0 mm × 100/31.1 mm = 41.8%. Legend:  
1 — urethral length, 2 — reflects the position of middle part of the 
tape on the axis of the urethra, 3 — distance of the middle part of the 
tape from the bladder neck, Bl — bladder, U — urethra, S — symphysis 
pubis, arrow — tape; B. Tape-urethra distance — 4.9 mm. Legend: 
1 — maximal distance between the tape and the hypoechoic urethra, 
2 — minimal distance between the tape and the hypoechoic urethra 
– tape-urethra distance, Bl — bladder, U — urethra, S — symphysis 
pubis, arrow — tape
A
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for SUI+ group, while the relative tape position was 55.8% 
(range = 41.5–71.2%) and 51.3% (range = 30.7–79.3%), re-
spectively to the group.
A normobile urethra (5 mm < vector value < 15 mm) was 
observed in thirteen women (41.9%). The treatment was suc-
cessful (SUI0) for only 2 patients (15.4%) from this group. Their 
respective tape-urethra distance was 1.9 and 2.5 [mm]. Despite 
a small sample, the differences in tape-urethra distance be-
tween groups SUI0 and SUI+ were quite close to statistically 
significant (p = 0.07). The tape-urethra distance in case of 
failed treatment (SUI+ group) was lower than 5 [mm] in 45.5% 
of cases and higher than 5 [mm] (up to 8.5 [mm]) in the rest 
of the cases, with a mean value of 5.2 [mm]. The relative tape 
position in groups SUI+ and SUI0 was similar and amounted 
to 55.6% and 52.2% (p = 0.72), respectively (Figure 3). In Figure 
3 we used the way of presentation, as well as values of optimal 
tape position and tape-urethra distance, published earlier in 
the literature by Kociszewski, Viereck et al. [12–14, 25].
A hypermobile urethra (vector value ≥ 15 [mm]) was 
observed in a total of eighteen women (58.1%), of which 
fourteen (77.8%) were treated successfully (SUI0). In this 
group the tape-urethra distance was ≤ 5 [mm] except one 
case of 6.1 [mm]. In most of patients from SUI0 group the 
relative tape position was between 50% and 70%. In 2 cases 
it was between 40% and 50%. In one case it was 71.2% with 
a tape-urethra distance of 3.4 [mm]. Out of the remaining 
hypermobile urethra patients 4 fell into the treatment fail-
ure group (SUI+), of which 3 had a relative tape position 
between 30% and 35% meaning that the tape was posi-
tioned to close to the neck of the bladder. In such case the 
tape-urethra distance was between 5.9 [mm] and 8.0 [mm]. 
The remaining case had a relative tape position of 54% 
and a tape-urethra distance of 6.2 [mm]. The differences 
in values of relative tape position between hypermobile 
urethra patients in groups SUI+ and SUI0 were statistically 
significant: 56.1% vs. 38.2% (p < 0.004). In 3 cases of failed 
treatment the value was between 30% and 36% (Figure 3). 
During PFS-TV we detected: 2 cases of tape being 
rolled-up (Figure 4), 1 case of tape detachment from a side 
and 3 cases of the tape being positioned asymmetrically 
around the urethra (Figure 5).
DISCUSSION
Studies showed that a TVT retropubic tape has some 
very good long-term results. Results of 17 years follow-up 
report that over 90% of women were objectively continent 
and 87% were subjectively cured or improved significantly 
[8]. Recently, some published studies and meta-analysis 
have suggested that mid-term results of TVT and TOT maybe 
quite similar [17, 27]. Complications after TVT and TVTO 
have led to the introduction of first SIMS - the TVT Secur™. 
However, the effects of SIMS implantation seem to fall short 
of expectations, especially at a longer time perspective [18]. 
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Figure 3. The SUI treatment results after Ajust implantation with respect 
to prior urethral mobility. A. In women with urethral normobility (vector 
value 5 mm < and < 15 mm); B. In women with hypermobility (vector 
value ≥ 15 mm). Legend:  cured (SUI0),  not-cured (SUI+)
Figure 4. PFS-TV — rolled-up tape (sagittal plane)
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Nowadays, there are a few SIMS available on the market, all 
of which are made of polypropylene. Yet, they differ, which 
may have an influence on biomechanical properties of tapes 
and on their respective cure rate [19, 20, 28]. Various success 
rates have been reported for SIMS during the last decade [26, 
27]. PFS-TV examination proved useful in detecting some 
of the differences in biomechanical properties between 
TVT and TVTO. For instance, it was noted that in order to 
achieve optimal results different place of incision is advised, 
i.e. formula 1/2 for TVTO and formula 1/3 for TVT [12, 13]. 
SIMS has some unquestionable advantages such as 
avoiding complications that are typical for TVT and TVTO like 
pain or injury in retropubic or transobturator spaces. Also, 
a smaller polypropylene tape is implanted [28]. The Ajust 
sling is the first SIMS, which just like TOT anchors to the 
obturator muscle or its membrane complex. During the 
procedure it is possible to adjust the tension of the tape 
[19]. Studies suggest that leaving a slight tension at the 
midurethra can improve the outcome [29]. It is also pos-
sible to loosen the TVT tape during the first few days after 
the procedure [30]. Yet, we did not find any information 
about it in the literature. In our patients there was no need 
to perform a procedure of loosening the sling since there 
was no case of permanent post-void residual. However, we 
recognize this as a potential problem since studies recom-
mend placing SIMS with a slight tension. 
Studies report a cure rate from SUI symptoms after 
12–29 months from inserting Ajust sling to be 80.0–84.7% 
[19, 31–34]. After Ajust implantation a statistically significant 
increase of Pdet and decrease of Qmax during voiding phase 
was observed in urodynamics. Yet, there were no signs of 
obstruction [19]. De novo urgency was noted in 7.8–21.7% 
of patients and de novo urge incontinence was noted in 
6.5% of patients [19, 33, 34]. In turn, after 3–5 years from 
Ajust implantation 51.6% of women from our study popula-
tion are reported as cured. De novo urgency was observed 
in 1 patient only (3.2%). We have no clear explanation for 
the difference between the results quoted in the literature 
and those of our study. We may only hypothesize a few 
reasons for such difference. Firstly, our study concerns first 
operative experience with Ajust so it may simply be the 
consequence of a learning curve. Secondly, studies suggest 
Figure 5. PFS-TV — tape symmetry analysis in axial plane. A. Symmetric tape; B. Asymmetric tape
A B
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that SIMS should be implanted with a little more tension 
than TVT [19, 31–34]. PFS-TV studies on TVT placement 
showed that a tape, which is positioned too close to the ure-
thra (tape-urethra distance < 3 mm) maybe responsible for 
a higher risk of urgency de novo and a post-void residual [12, 
13]. In contrast to the results of other studies, only 1 patient 
informed about urgency de novo in our study population. 
It could be then that we had inserted the tape less tightly 
than other authors, which has yielded a lower cure rate but 
at the same time a lower rate of urge de novo. 
In previous studies Kociszewski et al. showed that 
optimal therapeutic window for both TVT and TVTO lies 
between 3 and 5 [mm] for the tape urethra distance and 
between 50% and 70% for the relative tape position. Failure 
rate for both tapes depends also on prior urethral mobility 
[12–14]. TOT implantation treated successfully 0%, 72% and 
88% of patients with hypomobile, normobile and hyper-
mobile urethra, respectively. TVT cured respectively 67%, 
76% and 100% of patients with hypomobile, normobile and 
hypermobile urethra. In the hypomobile urethra group the 
optimal tape-urethra distance for TVT was not 3–5 [mm] 
but 2.5–3.5 [mm], while in the hypermobile group it was 
3–7 [mm]. Our study in turn indicates that for Ajust tape the 
optimal tape-urethra distance is ≤ 2.5 [mm] and 3–5 [mm], 
respectively for normobile and hypermobile urethra pa-
tients. These results need to be confirmed with a larger 
population study, preferably a prospective one. Our rela-
tive tape position in most cases was between 50 and 70%, 
which means no conclusions can be drawn with respect to 
an optimal therapeutic window for Ajust tape. Our results 
confirm that tape location near the bladder neck (relative 
tape position < 40%) is often the reason for failure.
The follow-up period could also be the reason for the 
high percentage of treatment failure since our study fol-
low-up period is considerably longer than that of other pub-
lications concerning Ajust tape. In a study comparing SIMS 
Miniarc with a retropubic tape the cure rate after 3 years 
from tape implantation was 47.4% for Miniarc vs. 91% for 
a retropubic tape [35]. However, authors did not mention 
tape-urethra distance or relative tape position.
The adverse results in our study include 2 cases of tape 
rolling up and 1 case of tape detachment from a side. In 
3 cases the tape was positioned asymmetrically. This may 
be due to the learning curve but short tape making the 
optimal positioning even more difficult is also an option. So 
far only one study in the literature has evaluated Ajust tape 
with ultrasound. The authors did not mention to encounter 
similar problems [20].
We found no studies similar to ours that would analyze 
the SIMS location, the urethral mobility and eventual treat-
ment success rates. 
Similarly to other studies we did not observe any signifi-
cant intraoperative or postoperative complications [19, 31–34]. 
Our study has some limitations. This is a retrospective 
study based on only first operative experience with Ajust 
while the number of patients is low. On the other hand 
only one and the same experienced surgeon performed 
the operations so the results may be close to the results 
obtained during first procedures in real clinical practice. 
Also, we have used PFS-TV so to objectively evaluate the 
postoperative continence as well as the tape location. This 
is the first study concerning SIMS where the effect of tape 
location was analyzed in light of the urethral mobility. In 
our opinion there is a high need to perform prospective 
comparative studies (SIMS vs. TVT or TOT) with a long ob-
servational period using ultrasound as one of the control 
method since our study confirms that there may be quite 
important differences between the available tapes and that 
the ultrasound examination may be an optimal universal 
tool for their evaluation and comparison.
CONCLUSIONS
Implantation of Ajust tape seems to be a safe mode of 
operative treatment of SUI in women. Our mid-term results 
suggest that the long-term effects might be worse than that 
of retropubic or transobturator tapes, especially at first op-
erative experience with Ajust. Urethral mobility seems to be 
an important risk factor for a treatment failure after Ajust 
implantation. It is possible that patients that may benefit 
from Ajust most are women with urethral hypomobility but 
this needs to be verified with a prospective study.
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